Act1 Adaptor Protein Is an Immediate and Essential Signaling Component of Interleukin-17 Receptor
Open accessThe DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.
Abstract
Interleukin (IL)-17, the founding member of the IL-17 cytokine family, is the hallmark of a novel subset of CD4+ T cells that is regulated by TGFbeta, IL-6, and IL-23. IL-17 plays an important role in promoting tissue inflammation in host defense against infection and in autoimmune diseases. Although IL-17 has been reported to regulate the expression of proinflammatory cytokines, chemokines, and matrix metalloproteinases, the signaling mechanism of IL-17 receptor has not been understood. An earlier study found that IL-17 activates NF-kappaB and MAPK pathways and requires TRAF6 to induce IL-6. However, it is unknown what molecule(s) directly associates with IL-17 receptor to initiate the signaling. We demonstrate here that IL-17 receptor family shares sequence homology in their intracellular region with Toll-IL-1 receptor (TIR) domains and with Act1, a novel adaptor previously reported as an NF-kappaB activator. MyD88 and IRAK4, downstream signaling components of TIR, are not required for IL-17 signaling. On the other hand, Act1 and IL-17 receptor directly associate likely via homotypic interaction. Deficiency of Act1 in fibroblast abrogates IL-17-induced cytokine and chemokine expression, as well as the induction of C/EBPbeta, C/EBPdelta, and IkappaBzeta. Also, absence of Act1 results in a selective defect in IL-17-induced activation of NF-kappaB pathway. These results thus indicate Act1 as a membrane-proximal adaptor of IL-17 receptor with an essential role in induction of inflammatory genes. Our study not only for the first time reveals an immediate signaling mechanism downstream of an IL-17 family receptor but also has implications in therapeutic treatment of various immune diseases.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Act1 is best understood as a nonredundant activator of IL-17RA-dependent signals”
From The IL-17 Family of Cytokines in Health and Disease (2019) · cites this paper as Chang et al., 2006
In the citing paper
“TRAF6 also promotes activation of MAPK/AP1 pathways and the C/EBPβ and δ transcription factors”
From The IL-17 Family of Cytokines in Health and Disease (2019) · cites this paper as Chang et al., 2006
Citations
Cites
A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17
Park, H., Li, Z., Yang, X. O., Chang, S. H., Nurieva, R., Wang, Y.-H., Wang, Y., Hood, L., Zhu, Z., Tian, Q., et al. (2005) · Nature Immunology · doi:10.1038/ni1261 · Cited by 4,265
Self-citationKawai, T., & Akira, S. (2006) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4401850 · Cited by 1,810
Th17: An Effector CD4 T Cell Lineage with Regulatory T Cell Ties
Weaver, C. T., Harrington, L. E., Mangan, P. R., Gavrieli, M., & Murphy, K. M. (2006) · Immunity · doi:10.1016/j.immuni.2006.06.002 · Cited by 1,422
Herpesvirus Saimiri encodes a new cytokine, IL-17, which binds to a novel cytokine receptor
Yao, Z., Fanslow, W. C., Seldin, M. F., Rousseau, A.-M., Painter, S. L., Comeau, M. R., Cohen, J. I., & Spriggs, M. K. (1995) · Immunity · doi:10.1016/1074-7613(95)90070-5 · Cited by 994
Cutting Edge: Interleukin 17 Signals through a Heteromeric Receptor Complex
Toy, D., Kugler, D., Wolfson, M., Bos, T. V., Gurgel, J., Derry, J., Tocker, J., & Peschon, J. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.1.36 · Cited by 570
Diversification of T-helper-cell lineages: finding the family root of IL-17-producing cells
Dong, C. (2006) · Nature Reviews Immunology · doi:10.1038/nri1807 · Cited by 487
Self-citationKao, C.-Y., Chen, Y., Thai, P., Wachi, S., Huang, F., Kim, C., Harper, R. W., & Wu, R. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.5.3482 · Cited by 424
Shalom-Barak, T., Quach, J., & Lotz, M. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.42.27467 · Cited by 388
Ruddy, M. J., Wong, G. C., Liu, X. K., Yamamoto, H., Kasayama, S., Kirkwood, K. L., & Gaffen, S. L. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m308809200 · Cited by 364
Schwandner, R., Yamaguchi, K., & Cao, Z. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.191.7.1233 · Cited by 349
Cited by
Items 101–200 of 366
IL-17R-EGFR axis links wound healing to tumorigenesis in Lrig1+ stem cells
Chen, X., Cai, G., Liu, C., Zhao, J., Gu, C., Wu, L., Hamilton, T. A., Zhang, C.-J., Ko, J., Zhu, L., et al. (2019) · Journal of Experimental Medicine · doi:10.1084/jem.20171849 · Cited by 106
“Upon ligand binding, the adaptor, Act1 (also known as CIKS), is recruited to the receptor, where it mediates downstream signaling (Chang et al., 2006; Qian et al., 2007).”
BackgroundIL-17RC: a partner in IL-17 signaling and beyond
Ho, A. W., & Gaffen, S. L. (2010) · Seminars in Immunopathology · doi:10.1007/s00281-009-0185-0 · Cited by 104
“It is currently unknown whether Act1, TRAF6, or other signaling intermediates bind directly to IL-17RC.”
InfluentialThe metabolism-modulating activity of IL-17 signaling in health and disease
Bechara, R., McGeachy, M. J., & Gaffen, S. L. (2021) · The Journal of Experimental Medicine · doi:10.1084/jem.20202191 · Cited by 104
Xie, S., Li, J., Wang, J. H., Wu, Q., Yang, P., Hsu, H.-C., Smythies, L. E., & Mountz, J. D. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0903133 · Cited by 102
“These results indicate that IL-17/IL-17RA signaling in B cells requires both TRAF6 and ACT1 and signals through the canonical NF-kB pathway to upregulate RGS16 expression, which inhibits chemotaxis in response to CXCL12.”
BackgroundInfluentialSuzukawa, M., Morita, H., Nambu, A., Arae, K., Shimura, E., Shibui, A., Yamaguchi, S., Suzukawa, K., Nakanishi, W., Oboki, K., et al. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1200461 · Cited by 105
“This suggests that IL-25, which can bind to IL-17RA (10), rather than IL-17A and IL-17F, may contribute to the responses.”
BackgroundInfluentialThe human IL-17A/F heterodimer: a two-faced cytokine with unique receptor recognition properties
Goepfert, A., Lehmann, S., Wirth, E., & Rondeau, J. (2017) · Scientific Reports · doi:10.1038/s41598-017-08360-9 · Cited by 107
Human inborn errors of immunity underlying superficial or invasive candidiasis
Puel, A. (2020) · Human Genetics · doi:10.1007/s00439-020-02141-7 · Cited by 109
Interleukin-17 regulation: an attractive therapeutic approach for asthma
Park, S. J., & Lee, Y. C. (2010) · Respiratory Research · doi:10.1186/1465-9921-11-78 · Cited by 111
“The expression of inflammation-related genes induced by IL-17 is abolished in Act1-deficient cells [41,42].”
BackgroundTh 17 cells interplay with Foxp3+ Tregs in regulation of inflammation and autoimmunity
Mai, J. (2010) · Frontiers in Bioscience · doi:10.2741/3657 · Cited by 93
“ACT1 contains a SEFIR domain in its C terminus (121, 122).”
BackgroundIL-17C/IL-17RE: Emergence of a Unique Axis in TH17 Biology
Nies, J. F., & Panzer, U. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00341 · Cited by 104
“Pathways activated by IL17 receptor signaling include nuclear factor kappa-light-chainenhancer of activated B cells (NF-κB) (58), inhibitor of NF-κB ζ (IκBζ) (59), mitogen-activated protein kinase (MAPK) (60– 62), and CCAAT/enhancer-binding protein (C/EBP) (63, 64).”
BackgroundHuR is required for IL-17-induced Act1-mediated CXCL1 and CXCL5 mRNA stabilization
Herjan, T., Yao, P., Qian, W., Li, X., Liu, C., Bulek, K., Sun, D., Yang, W.-P., Zhu, J., He, A., et al. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1203315 · Cited by 95
“Act1 (also known as CIKS) is an essential component in IL-17 signaling and required for IL-17– dependent immune responses (15, 18, 19).”
BackgroundT cell mediated pathogenesis in EAE: Molecular mechanisms
Kurschus, F. C. (2015) · Biomedical Journal · doi:10.4103/2319-4170.155590 · Cited by 103
“IL‐17A, F, and C signal by a unique pathway, utilizing NF‐kB activator 1 (ACT1)/tumor necrosis factor receptor associated factor (TRAF) 6,([50,51]) with nuclear fac‐ tor kappa‐light‐chain‐enhancer of activated B cells (NF‐kB) playing an important role as the downstream pathway.”
MethodInflammasome activation and Th17 responses
Deng, J., Yu, X.-Q., & Wang, P.-H. (2019) · Molecular Immunology · doi:10.1016/j.molimm.2018.12.024 · Cited by 93
TH17 cells in asthma and inflammation
Aujla, S. J., & Alcorn, J. F. (2011) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2011.02.002 · Cited by 104
IL-17 Signaling for mRNA Stabilization Does Not Require TNF Receptor-Associated Factor 6
Hartupee, J., Liu, C., Novotny, M., Sun, D., Li, X., & Hamilton, T. A. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.182.3.1660 · Cited by 88
“Using mice deficient in Act1, this signaling adaptor was found to be required both for response to IL-17 alone and for the more robust responses seen with the combination of IL-17 and TNF- (21, 22).”
Genomics of fish IL-17 ligand and receptors: A review
Kono, T., Korenaga, H., & Sakai, M. (2010) · Fish & Shellfish Immunology · doi:10.1016/j.fsi.2010.11.028 · Cited by 96
Prinz, I., Sandrock, I., & Mrowietz, U. (2019) · The Journal of Experimental Medicine · doi:10.1084/jem.20191397 · Cited by 91
Toh, M., Gonzales, G., Koenders, M. I., Tournadre, A., Boyle, D., Lubberts, E., Zhou, Y., Firestein, G. S., van den Berg, W. B., & Miossec, P. (2010) · PLoS ONE · doi:10.1371/journal.pone.0013416 · Cited by 90
“Cytokine induced ERK MAPK and Ets 1 transcription factor have been reported to control synoviolin expression in mouse cells [5].”
BackgroundInfluentialQu, F., Gao, H., Zhu, S., Shi, P., Zhang, Y., Liu, Y., Jallal, B., Yao, Y., Shi, Y., & Qian, Y. (2012) · Molecular and Cellular Biology · doi:10.1128/mcb.00268-12 · Cited by 87
“Act1 is identified as a key adaptor to recruit TRAF6 to IL-17R to mediate IL-17-induced NF- B activation, while TRAF3 and TRAF4 are found to interfere with the complex formation of IL-17R-Act1TRAF6 (3, 27, 37, 38).”
BackgroundBechara, R., Amatya, N., Bailey, R. D., Li, Y., Aggor, F. E. Y., Li, D.-D., Jawale, C. V., Coleman, B. M., Dai, N., Gokhale, N. S., et al. (2021) · Science Immunology · doi:10.1126/sciimmunol.abd1287 · Cited by 89
Organizing structural principles of the IL-17 ligand–receptor axis
Wilson, S. C., Caveney, N. A., Yen, M., Pollmann, C., Xiang, X., Jude, K. M., Hafer, M., Tsutsumi, N., Piehler, J., & Garcia, K. C. (2022) · Nature · doi:10.1038/s41586-022-05116-y · Cited by 84
Dainichi, T., Matsumoto, R., Mostafa, A., & Kabashima, K. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01107 · Cited by 96
“ACT1 Deficiency of ACT1 in fibroblast results in a selective defect in IL-17-induced activation of an NF-κB pathway and abrogates IL-17-induced cytokine and chemokine expression (49).”
BackgroundStructure and function of interleukin-17 family cytokines
Zhang, X., Angkasekwinai, P., Dong, C., & Tang, H. (2011) · Protein & Cell · doi:10.1007/s13238-011-1006-5 · Cited by 96
Self-citationIL-17B: A new area of study in the IL-17 family
Bie, Q., Jin, C., Zhang, B., & Dong, H. (2017) · Molecular Immunology · doi:10.1016/j.molimm.2017.07.004 · Cited by 87
“The cytokines of the IL-17 family mediate signaling through a novel ACT1-dependent pathway, culminating in the activation of proinflammatory factors, such as nuclear factor (NF)-κB, which are typically associated with innate immune signaling (Chang et al., 2006; Gaffen, 2009).”
BackgroundIL-17A Synergistically Enhances Bile Acid–Induced Inflammation during Obstructive Cholestasis
O'Brien, K. M., Allen, K. M., Rockwell, C. E., Towery, K., Luyendyk, J. P., & Copple, B. L. (2013) · The American Journal of Pathology · doi:10.1016/j.ajpath.2013.07.019 · Cited by 82
Zhang, J., Fu, Q., Ren, Z., Wang, Y., Wang, C., Shen, T., Wang, G., & Wu, L. (2015) · Gynecological Endocrinology · doi:10.3109/09513590.2014.975683 · Cited by 79
“First, the binding of IL-17 with its receptor activated two pathways, namely the NF-jB and mitogen-activated protein kinases (MAPKs) [24]; furthermore, Act-1, an activator of NF-jB pathway, is also required for IL-17-mediated signal transduction process [25,26].”
BackgroundClinical implication of recent advances in our understanding of IL-17 and reproductive immunology
Saito, S., Nakashima, A., Ito, M., & Shima, T. (2011) · Expert Review of Clinical Immunology · doi:10.1586/eci.11.49 · Cited by 84
Interleukin‐17 and ischaemic stroke
Zhang, Q., Liao, Y., Liu, Z., Dai, Y., Li, Y., Li, Y., & Tang, Y. (2020) · Immunology · doi:10.1111/imm.13265 · Cited by 87
IL-17RD (Sef or IL-17RLM) interacts with IL-17 receptor and mediates IL-17 signaling
Rong, Z., Wang, A., Li, Z., Ren, Y., Cheng, L., Li, Y., Wang, Y., Ren, F., Zhang, X., Hu, J., et al. (2008) · Cell Research · doi:10.1038/cr.2008.320 · Cited by 86
Zhou, J., An, X., Dong, J., Wang, Y., Zhong, H., Duan, L., Ling, J., Ping, F., & Shang, J. (2018) · The FASEB Journal · doi:10.1096/fj.201701242rr · Cited by 84
Zimmermann, J., Krauthausen, M., Hofer, M. J., Heneka, M. T., Campbell, I. L., & Müller, M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0057307 · Cited by 75
“TRAF6 and the adaptor protein Act-1 signaling [39,40] thus leading to the expression of many proinflammatory cytokines,”
BackgroundZepp, J. A., Liu, C., Qian, W., Wu, L., Gulen, M. F., Kang, Z., & Li, X. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1200470 · Cited by 73
“Act1 (NF-kB activator 1, or CIKS), also a member of the SEFIR protein family, is an essential E3-ligase in IL-17 signaling and is required for IL-17–dependent immune responses (5, 6).”
BackgroundYin and yang of interleukin-17 in host immunity to infection
Das, S., & Khader, S. A. (2017) · F1000Research · doi:10.12688/f1000research.10862.1 · Cited by 78
“In addition, NF-κ B activator 1 (Act1) is important for IL-17R signaling, where it acts as an adapter molecule for the recruitment of TRAF-6 with IL-17R 14,15 .”
BackgroundJAK/STAT pathway and nociceptive cytokine signalling in rheumatoid arthritis and psoriatic arthritis
Crispino, N., & Ciccia, F. (2021) · Clinical and Experimental Rheumatology · doi:10.55563/clinexprheumatol/e7ayu8 · Cited by 73
Differentiation and function of pro-inflammatory Th17 cells
Dong, C. (2009) · Microbes and Infection · doi:10.1016/j.micinf.2009.04.001 · Cited by 81
“Studies in our laboratory demonstrated that the SEFIR domain in IL-17R directly interacts with an NF-kB activator protein, Act1 [55].”
Self-citationTPL2 mediates autoimmune inflammation through activation of the TAK1 axis of IL-17 signaling
Xiao, Y., Jin, J., Chang, M., Nakaya, M., Hu, H., Zou, Q., Zhou, X., Brittain, G. C., Cheng, X., & Sun, S.-C. (2014) · Journal of Experimental Medicine · doi:10.1084/jem.20132640 · Cited by 71
“The cytoplasmic region of IL-17R contains a signaling domain, the SEF/IL-17R domain, which interacts with the adaptor protein ACT1 (also called CIKS) in response to IL-17 stimulation (Novatchkova et al., 2003; Chang et al., 2006; Qian et al., 2007).”
BackgroundSong, M., Liang, J., Wang, L., Li, W., Jiang, S., Xu, S., Tang, L., Du, Q., Liu, G., Meng, H., et al. (2023) · International Immunopharmacology · doi:10.1016/j.intimp.2023.110757 · Cited by 74
Th17 Differentiation and Their Pro-inflammation Function
Song, X., Gao, H., & Qian, Y. (2014) · Advances in experimental medicine and biology · doi:10.1007/978-94-017-9487-9_5 · Cited by 74
“After IL-17 stimulation, IL-17R recruited Act1 to its intracellular region through SEFIR-SEFIR domain interaction [27, 220].”
BackgroundAct1 modulates autoimmunity through its dual functions in CD40L/BAFF and IL-17 signaling.
Li, X.-X. (2008) · Cytokine · doi:10.1016/j.cyto.2007.09.015 · Cited by 78
Huang, S. U.-S., & O’Sullivan, K. M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23073793 · Cited by 80
Saran, A., Nishizaki, D., Lippman, S. M., Kato, S., & Kurzrock, R. (2025) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2025.01.002 · Cited by 71
Huang, S. U.-S., & O’Sullivan, K. M. (2022) · doi:10.20944/preprints202203.0021.v1 · Cited by 65
Immune regulation of bone loss by T h17 cells in oestrogen‐deficient osteoporosis
Zhao, R. (2013) · European Journal of Clinical Investigation · doi:10.1111/eci.12158 · Cited by 66
Targeting IL-17 in autoimmunity and inflammation
Kim, B. S., Park, Y.-J., & Chung, Y. (2016) · Archives of Pharmacal Research · doi:10.1007/s12272-016-0823-8 · Cited by 65
An in‐depth analysis of the immunomodulatory mechanisms of intervertebral disc degeneration
Song, C., Cai, W., Liu, F., Cheng, K., Guo, D., & Liu, Z. (2022) · JOR Spine · doi:10.1002/jsp2.1233 · Cited by 63
Ahmad, R., Sylvester, J., & Zafarullah, M. (2007) · Cellular Signalling · doi:10.1016/j.cellsig.2007.08.013 · Cited by 67
Cytokine control of inflammation and repair in the pathology of multiple sclerosis.
Rodgers, J. M., & Miller, S. D. (2012) · PubMed Central · Cited by 70
Rosani, U., Varotto, L., Gerdol, M., Pallavicini, A., & Venier, P. (2015) · Developmental & Comparative Immunology · doi:10.1016/j.dci.2015.05.001 · Cited by 61
“The crucial element of the IL-17 signaling is the SEF/IL-17R (SEFIR) domain which displays similarity to the Toll/IL1 (TIR) domain and mediates the interaction between the cytoplasmic tail of IL-17Rs and CIKS (alias Act1 or TRAFIP2), a proximate adaptor protein with TRAF-binding motifs (Chang et al., 2006; Novatchkova…”
BackgroundSEF/IL-17R (SEFIR) Is Not Enough
Onishi, R. M., Park, S. J., Hanel, W., Ho, A. W., Maitra, A., & Gaffen, S. L. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.121418 · Cited by 56
Ge, D., Dauchy, R. T., Liu, S., Zhang, Q., Mao, L., Dauchy, E. M., Blask, D. E., Hill, S. M., Rowan, B. G., Brainard, G. C., et al. (2013) · Journal of Pineal Research · doi:10.1111/jpi.12084 · Cited by 58
“Recently, it has been shown that GSK3B phosphorylates C/EBPd at threonine 156, leading to degradation of C/EBPd, thus attenuating Tolllike receptor 4-induced inflammation-associated genes in macrophages and tumor cells [45].”
BackgroundInfluentialLiu, C., Swaidani, S., Qian, W., Kang, Z., Sun, P., Han, Y., Wang, C., Gulen, M. F., Yin, W., Zhang, C., et al. (2011) · Science Signaling · doi:10.1126/scisignal.2001843 · Cited by 54
“Nuclear factor kB (NF-kB) activator 1 (Act1) is an adaptor protein and E3 ubiquitin ligase that is critical for signaling by either IL-17 or IL-25, and it is recruited to their receptors (IL-17R and IL-25R) through heterotypic interactions between the SEFIR [SEF (similar expression to fibroblast growth factor genes) a…”
BackgroundInfluentialLing, Y., & Puel, A. (2014) · Actas Dermo-Sifiliográficas · doi:10.1016/s0001-7310(14)70016-x · Cited by 57
IL-17 promotes osteoblast differentiation, bone regeneration, and remodeling in mice
Kim, H. J., Seo, S. J., Kim, J., Kim, Y., & Lee, Y. (2020) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2020.02.054 · Cited by 59
Shi, P., Zhu, S., Lin, Y., Liu, Y., Liu, Y., Chen, Z., Shi, Y., & Qian, Y. (2011) · Science Signaling · doi:10.1126/scisignal.2001653 · Cited by 50
“Studies have begun to unveil the mechanisms of IL-17R signaling (6, 27, 30, 31, 34, 35, 48).”
BackgroundInfluentialIL-17 and IL-21: Their Immunobiology and Therapeutic Potentials
Koh, C., Kim, B., Kang, C., Chung, Y., & Seo, H. (2024) · Immune Network · doi:10.4110/in.2024.24.e2 · Cited by 56
“24.e2 3/24 https://immunenetwork.org domain, which is crucial for its association with IL-17R (20,21).”
BackgroundInfluentialPaunović, V., Carroll, H. P., Vandenbroeck, K., & Gadina, M. (2008) · Rheumatology · doi:10.1093/rheumatology/kem352 · Cited by 58
Kurschus, F. C., & Moos, S. (2017) · Journal of Dermatological Science · doi:10.1016/j.jdermsci.2017.06.010 · Cited by 59
Therapeutic Development Based on the Immunopathogenic Mechanisms of Psoriasis
Tseng, J., Chang, Y.-C., Huang, C., Hsu, L.-C., & Chuang, T. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13071064 · Cited by 56
“pathway that involves TRAF6 and TAK1, thus activating NF-κB [85,86].”
BackgroundEvasovic, J. M., & Singer, C. A. (2019) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00416.2018 · Cited by 57
IL-17D: A Less Studied Cytokine of IL-17 Family
Liu, X., Sun, S., & Liu, D. (2020) · International Archives of Allergy and Immunology · doi:10.1159/000508255 · Cited by 51
Interleukin-17 as a key player in neuroimmunometabolism
Douglas, A., Stevens, B., & Lynch, L. (2023) · Nature Metabolism · doi:10.1038/s42255-023-00846-3 · Cited by 49
Prolactin enhances basal and IL‐17‐induced CCL20 production by human keratinocytes
Kanda, N., Shibata, S., Tada, Y., Nashiro, K., Tamaki, K., & Watanabe, S. (2009) · European Journal of Immunology · doi:10.1002/eji.200838852 · Cited by 49
Suyama, K., Sakai, D., & Watanabe, M. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.857164 · Cited by 52
“NF-κB activator 1 (Act1) contains a SEFIR domain and TRAF6 binding motif (Chang et al., 2006; Li et al., 2007).”
BackgroundRETRACTED: Enhanced IL-17 signalling following myocardial ischaemia/reperfusion injury
Barry, S. P., Ounzain, S., McCormick, J., Scarabelli, T. M., Chen-Scarabelli, C. A., Saravolatz, L. I. I., Faggian, G. G., Mazzucco, A., Suzuki, H., Thiemermann, C., et al. (2011) · International Journal of Cardiology · doi:10.1016/j.ijcard.2011.08.849 · Cited by 50
“involved in inflammatory arthritis, Crohn's disease, psoriasis and multiple sclerosis [9–11].”
BackgroundRetractedRoles for TNF-receptor associated factor 3 (TRAF3) in lymphocyte functions
Yi, Z., Lin, W., Stunz, L. L., & Bishop, G. A. (2013) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2013.12.002 · Cited by 52
New insights into the function of Interleukin-25 in disease pathogenesis
Yuan, Q., Peng, N., Xiao, F., Shi, X., Zhu, B., Rui, K., Tian, J., & Lu, L. (2023) · Biomarker Research · doi:10.1186/s40364-023-00474-9 · Cited by 54
“Act1 both exhibits E3 ubiquitin ligase activity and also includes a SEFIR structural domain containing a CC’ loop peptide [7, 10, 11].”
BackgroundNovel systemic drugs under investigation for the treatment of psoriasis
Gudjonsson, J. E., Johnston, A. W. B., & Ellis, C. N. (2012) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2011.06.037 · Cited by 49
Doyle, M. S., Collins, E. S., FitzGerald, O., & Pennington, S. R. (2012) · Arthritis Research & Therapy · doi:10.1186/ar4071 · Cited by 49
Sivanathan, K. N., Rojas-Canales, D., Grey, S. T., Gronthos, S., & Coates, P. T. (2017) · Stem Cells International · doi:10.1155/2017/1025820 · Cited by 41
FGF2 cooperates with IL-17 to promote autoimmune inflammation
Shao, X., Chen, S., Yang, D., Cao, M., Yao, Y., Wu, Z., Li, N., Shen, N., Li, X., Song, X., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-07597-8 · Cited by 46
Neddylation-Independent Activities of MLN4924
Mao, H., & Sun, Y. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-981-15-1025-0_21 · Cited by 45
Association of IL-17A and IL-17 F gene polymorphisms with recurrent pregnancy loss in Iranian women
Najafi, S., Hadinedoushan, H., Eslami, G., & Aflatoonian, A. (2014) · Journal of Assisted Reproduction and Genetics · doi:10.1007/s10815-014-0294-0 · Cited by 46
“Binding IL-17 to its receptor initiates signalling pathways which induce the production of proinflammatory cytokines and chemokines and induce the recruitment of neutrophils [9, 10].”
BackgroundInterleukin-25: A two-edged sword in the control of immune-inflammatory responses
Monteleone, G., Pallone, F., & MacDonald, T. T. (2010) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2010.05.001 · Cited by 50
Chen, C., Zhang, Q., Liu, S., Parajuli, K. R., Qu, Y., Mei, J., Chen, Z., Zhang, H., Khismatullin, D. B., & You, Z. (2015) · The Prostate · doi:10.1002/pros.22971 · Cited by 42
“When it binds to a heterodimer of IL-17RA/IL-17RC receptor complex, IL-17 is able to activate nuclear factor-kB (NF-kB) activator 1 (Act1) through SEFIR (similar expression to fibroblast growth factor genes, IL-17 receptors, and Toll-IL-1R) domains [11–15].”
BackgroundAn Organismal Model for Gene Regulatory Networks in the Gut-Associated Immune Response
Buckley, K. M., & Rast, J. P. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01297 · Cited by 45
IκBζ is a key player in the antipsoriatic effects of secukinumab
Bertelsen, T., Ljungberg, C., Litman, T., Huppertz, C., Hennze, R., Rønholt, K., Iversen, L., & Johansen, C. (2019) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2019.09.029 · Cited by 46
Interleukin-17A in lipid metabolism and atherosclerosis
Yu, X., Jiang, N., Zheng, X., Cayabyab, F. S., Tang, Z.-B., & Tang, C. (2014) · Clinica Chimica Acta · doi:10.1016/j.cca.2014.01.012 · Cited by 42
IL-17 Signaling-Independent Central Nervous System Autoimmunity Is Negatively Regulated by TGF-β
González-García, I., Zhao, Y., Ju, S., Gu, Q., Liu, L., Kolls, J. K., & Lu, B. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0802221 · Cited by 42
“In addition, Act1, a molecule within the IL-17 signal transduction pathway is required for EAE (18, 19).”
BackgroundDownregulation of Chicken Interleukin-17 Receptor A during Eimeria Infection
Kim, W. H., Jeong, J., Park, A. R., Yim, D., Kim, S., Chang, H. H., Yang, S. H., Kim, D., Lillehoj, H. S., & Min, W. (2014) · Infection and Immunity · doi:10.1128/iai.02141-14 · Cited by 42
Zhang, B., Liu, C., Qian, W., Han, Y., Li, X., & Deng, J. (2014) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s1399004714005227 · Cited by 38
TRAF 3, ubiquitination, and B‐lymphocyte regulation
Lin, W., Hostager, B. S., & Bishop, G. A. (2015) · Immunological Reviews · doi:10.1111/imr.12299 · Cited by 44
Interleukin-17F signaling requires ubiquitination of interleukin-17 receptor via TRAF6
Rong, Z., Cheng, L., Ren, Y., Li, Z., Li, Y., Li, X., Li, H., Fu, X.-Y., & Chang, Z. (2007) · Cellular Signalling · doi:10.1016/j.cellsig.2007.01.025 · Cited by 40
Human colon carcinogenesis is associated with increased interleukin-17-driven inflammatory responses
Xie, Z.-H., Qu, Y., Leng, Y., Sun, W., Ma, S., Wei, J., Hu, J.-G., & Zhang, X. (2015) · Drug Design Development and Therapy · doi:10.2147/dddt.s79431 · Cited by 43
Crystal Structure of IL-17 Receptor B SEFIR Domain
Zhang, B., Liu, C., Qian, W., Han, Y., Li, X., & Deng, J. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1202922 · Cited by 38
Hong, J.-S., Greenlee, K. J., Pitchumani, R., Lee, S., Song, L., Shan, M., Chang, S. H., Park, P. W., Dong, C., Werb, Z., et al. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1003449 · Cited by 45
“In response to IL17A, fibroblasts express GM-CSF, IL-6, and IL-8, which are critical for the proliferation of hematopoietic progenitor cells and the maturation of PMNs (32).”
Self-citationPyruvate kinase M2 mediates IL-17 signaling in keratinocytes driving psoriatic skin inflammation
Veras, F. P., Públio, G. A., de Melo, B. M. S., Prado, D. D. S., Norbiato, T., Cecílio, N. T., Hiroki, C. H., Damasceno, L. E. A., Jung, R., Toller-Kawahisa, J. E., et al. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.111897 · Cited by 38
IL-23/IL-17 Biology and Therapeutic Considerations
Dong, C. (2008) · Journal of Immunotoxicology · doi:10.1080/15476910801897953 · Cited by 38
“The receptor for IL-17 is ubiquitously distributed in various tissues and upon ligation by IL-17 it induces signaling pathways in through Act1 and TRAF6 molecules (Chang et al., 2006; Schwandner et al., 2000).”
BackgroundSelf-citationCIKS/DDX3X Interaction Controls the Stability of the Zc3h12a mRNA Induced by IL-17
Somma, D., Mastrovito, P., Grieco, M., Lavorgna, A., Pignalosa, A., Formisano, L., Salzano, A. M., Scaloni, A., Pacifico, F., Siebenlist, U., et al. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1401589 · Cited by 36
The Role of IL-17 in the Pathogenesis of Oral Squamous Cell Carcinoma
Ladjevac, N., Milovanović, M., Jevtović, A., Arsenijević, D., Stojanović, B., Stojanovic, M. D., Stojanović, B., Arsenijević, N., Arsenijević, A., & Milovanović, J. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24129874 · Cited by 39
“The cytosolic adaptor Act1 contains a SEFIR domain and interacts with IL-17RA and IL-17RC through homotypic SEFIR interactions leading to the activation of all IL-17-dependent signaling pathways [68,69].”
BackgroundDiversity in post-transcriptional control of neutrophil chemoattractant cytokine gene expression
Hamilton, T., Novotny, M., Pavicic, P. J., Herjan, T., Hartupee, J., Sun, D., Zhao, C., & Datta, S. (2010) · Cytokine · doi:10.1016/j.cyto.2010.04.003 · Cited by 36
“the intracellular region and is able to interact with another SEFIR domain-containing adaptor protein termed Act1, which is necessary for most responses to IL-17 [75,76].”
FYN–TRAF3IP2 induces NF-κB signaling-driven peripheral T-cell lymphoma
Moon, C. S., Reglero, C., Cortés, J. R., Quinn, S. A., Álvarez, S., Zhao, J., Lin, W.-H. W., Cooke, A. J., Abate, F., Soderquist, C. R., et al. (2021) · Nature Cancer · doi:10.1038/s43018-020-00161-w · Cited by 37
Pisitkun, P., Claudio, E., Ren, N., Wang, H., & Siebenlist, U. (2010) · Arthritis & Rheumatism · doi:10.1002/art.27653 · Cited by 36
Update on the role of Interleukin 17 in rheumatologic autoimmune diseases
Konya, C., Paz, Z., Apostolidis, S. A., & Tsokos, G. C. (2015) · Cytokine · doi:10.1016/j.cyto.2015.01.003 · Cited by 35
Du, S., Li, Z., Xie, X., Xu, C., Shen, X., Wang, N., & Shen, Y. (2019) · Scandinavian Journal of Immunology · doi:10.1111/sji.12840 · Cited by 39
Zhang, Z., Li, X., Guo, J., Xu, F., He, Q., Zhao, Y., Yang, Y., Gu, S., Zhang, Y., Wu, L., et al. (2013) · European Journal Of Haematology · doi:10.1111/ejh.12074 · Cited by 35
“These pathways then promote the production of pathogenic cytokines, such as IFN-c and TNF-a, which then promote the apoptosis of haematopoietic cells and result in BM failure (28, 29).”
BackgroundArtificial macrocycles as IL-17A/IL-17RA antagonists
Wang, W., Groves, M. R., & Dömling, A. S. S. (2018) · MedChemComm · doi:10.1039/c7md00464h · Cited by 34
Systematic analysis of the IL ‐17 receptor signalosome reveals a robust regulatory feedback loop
Draberova, H., Janusova, S., Knizkova, D., Semberova, T., Pribikova, M., Ujevic, A., Harant, K., Knapkova, S., Hrdinka, M., Fanfani, V., et al. (2020) · The EMBO Journal · doi:10.15252/embj.2019104202 · Cited by 35
“First, we observed that cells deficient in ACT1, the very proximal IL-17R-interacting protein (Chang et al , 2006; Qian et al , 2007), show completely disrupted IL-17RSC formation (Fig 4A and Table EV4) and disabled the activation of TBK1 and IKK e upon IL-17 stimulation (Fig EV4A).”
Goepfert, A., Barske, C., Lehmann, S., Wirth, E., Willemsen, J., Gudjonsson, J. E., Ward, N. L., Sarkar, M. K., Hemmig, R., Kolbinger, F., et al. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.111489 · Cited by 40
“While IL-17 signaling does not involve any DDcontaining proteins, the SEFIR domain plays a similar role as the TIR domain in mediating the initial, membrane-proximal recruitment of the multifunctional adaptor protein, Act1, through SEFIR-SEFIR interactions (Chang et al., 2006; Qian et al., 2007).”
Mohamed, Y. T., Salama, A., Rabie, M. A., & Fattah, M. A. A. E. (2022) · International Immunopharmacology · doi:10.1016/j.intimp.2022.109571 · Cited by 37
A Role for the Cytoplasmic Adaptor Protein Act1 in Mediating IL-17 Signaling
Lindén, A. (2007) · Science's STKE · doi:10.1126/stke.3982007re4 · Cited by 35
Metadata
- Authors
- Chang, S. H., Park, H., & Dong, C.
- Affiliations
- The University of Texas MD Anderson Cancer Center (US)
- University of Washington (US)
- Corresponding author
- Dong, Chen
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2006-11
- Volume
- 281
- Issue
- 47
- Pages
- 35603-35607
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W221516563
- Cited by
- 356
- References
- 17
- Citations by year
- 2026: 11 · 2025: 14 · 2024: 8 · 2023: 16 · 2022: 16 · 2021: 19 · 2020: 14 · 2019: 16 · 2018: 12 · 2017: 17 · 2016: 14 · 2015: 20 · 2014: 21 · 2013: 24 · 2012: 23
- FWCI
- 7.18
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- creativecommons.org/licenses/by/4.0/ (vor, 5082 d)
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › NF-κB Signaling Pathways
- Life Sciences › Immunology and Microbiology › Immunology › Cytokine Signaling Pathways and Interactions
- Life Sciences › Immunology and Microbiology › Immunology › Psoriasis: Treatment and Pathogenesis
- Keywords
- interleukin-17 receptor, IL-17 signaling, NF-κB activation, C/EBPβ, C/EBPδ, chemokine expression, fibroblasts, inflammatory gene expression
- MeSH terms
- Animals, Humans, Inflammation, Mice, Inbred C57BL, Nuclear Proteins, Phylogeny, Protein Binding, Transcription, Genetic, Signal Transduction, CD4-Positive T-Lymphocytes, Protein Structure, Tertiary, MAP Kinase Signaling System, Adaptor Proteins, Signal Transducing, Mice, Receptors, Interleukin-17
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.